About Tome Biosciences

Tome Biosciences is the programmable gene insertion company. Using CRISPR, our technologies allow us to insert any genetic sequence of any size at any location into any genome. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and genome engineering.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology Research
location icon
Headquarter
AOTC, Watertown, Massachusetts, US
description icon
Founded
None

Tome Biosciences Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Tome Biosciences

Who is the CEO of Tome Biosciences?

Rahul Kakkar is the CEO of Tome Biosciences. To contact Rahul Kakkar email at [email protected]. Or you may call +0.6175432683

Who are the decision makers in Tome Biosciences?

The decision makers in Tome Biosciences are Antony Hsieh, Jenny Xie, Michelle Avery, etc. Click to Find Tome Biosciences decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more